# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k060429   
B. Purpose for Submission: Clearance of new device   
C. Measurand: Assayed controls for acetaminophen, amikacin, carbamazepine, digoxin, gentamicin, lidocaine, N-acetyl procainamide, phenobarbital, phenytoin, primidone, procainamide, quinidine, salicylate, theophylline, tobramycin, valproic acid and vancomycin.   
D. Type of Test: Not applicable.   
E. Applicant: Roche Diagnostics Corporation   
F. Proprietary and Established Names: TDM Control Set   
G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>Multi-Analyte Controls(Assayed And Unassayed)(JJY)</td><td rowspan=1 colspan=1>Class I</td><td rowspan=1 colspan=1>21 CFR 862.1660.Quality controlmaterial (assayed andunassayed).</td><td rowspan=1 colspan=1>75 ClinicalChemistry(CH)</td></tr></table>

# H. Intended Use:

1. Intended use(s): See Indications for Use below.

2. Indication(s) for use:

The TDM Control Set is intended for use as an assayed quality control product on Roche/Hitachi and COBAS INTEGRA analyzers. Three assayed levels of acetaminophen, amikacin, carbamazepine, digoxin, gentamicin, lidocaine, N-acetyl procainamide, phenobarbital, phenytoin, primidone, procainamide, quinidine, salicylate, theophylline, tobramycin, valproic acid and vancomycin are provided.

3. Special conditions for use statement(s): For Prescription use only

4. Special instrument requirements:

Roche/Hitachi and COBAS Integra analyzers

# I. Device Description:

The TDM Control Set is a human serum based liquid control with seventeen added therapeutic drugs, preservative and stabilizer. The drugs are acetaminophen, amikacin, carbamazepine, digoxin, gentamicin, lidocaine, N-acetylprocainamide, phenobarbital, phenytoin, primidone, procainamide, quinidine, salicylate, theophylline, tobramycin, valproic acid and vancomycin.

Each TDM Control Set contains 2 bottles of controls (a $5 . 0 \mathrm { m l }$ fill volume per bottle) at Levels 1, II and III.

# J. Substantial Equivalence Information:

1. Predicate device name(s): CLINIQA Liquid QC TDM Controls Levels, 1, 2, & 3

2. Predicate 510(k) number(s): k041898

3. Comparison with the Predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Assayed quality control material</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Three</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum based liquid</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate</td></tr><tr><td colspan="1" rowspan="1">Number ofConstituents</td><td colspan="1" rowspan="1">Seventeen</td><td colspan="1" rowspan="1">Nineteen</td></tr><tr><td colspan="1" rowspan="1">Constituents</td><td colspan="1" rowspan="1">acetaminophen, amikacin,carbamazepine, digoxin, gentamicin,lidocaine, N-acetylprocainamide,phenobarbital, phenytoin, primidone,procainamide, quinidine, salicylate,theophylline, tobramycin, valproicacid and vancomycin.</td><td colspan="1" rowspan="1">acetaminophen, amikacin,carbamazepine, disopyramide,digoxin, ethosuximide,gentamicin, lidocaine, N-acetylprocainamide,phenobarbital, phenytoin,primidone, procainamide,quinidine, salicylate,</td></tr><tr><td colspan="1" rowspan="1">Constituents</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">theophylline, tobramycin,valproic acid and vancomycin.</td></tr><tr><td colspan="1" rowspan="1">TargetRange</td><td colspan="1" rowspan="1">Different assigned values</td><td colspan="1" rowspan="1">Different assigned values</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

1. ISO 14971:2000, Medical Devices – Application of risk management to medical devices.   
2. FDA Guidance: Format for Traditional and Abbreviated $5 1 0 ( \mathrm { k } ) \mathrm { s }$ .   
3. FDA Guidance: Points to Consider Guidance Document on Assayed and Unassayed Quality Control Material; Draft.   
4. FDA Guidance: Points to Consider for Review of Calibration and Quality Control Labeling for In Vitro Diagnostic Devices.

# L. Test Principle:

Not applicable.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: Not applicable

b. Linearity/assay reportable range: Not applicable

Roche Diagnostics maintains a set of master calibrators for each assay that have values assigned that are traceable to the various reference standards. The TDM Control Set products are assayed and traceable to USP standards. Values are assigned using the Hitachi 917, Module P and COBAS Integra $4 0 0 / 7 0 0 / 8 0 0$ analyzers. A minimum of two independent series of analyses are performed on each instrument for each analyte. Each sample is tested in duplicate. The target value is then calculated as the median of the determined values. The following tables list lot-specific target values and ranges.

Lot 674373   

<table><tr><td>TDM Control Set</td><td>Lot 674373</td><td>Level 1</td><td></td><td>Unit</td></tr><tr><td>Component</td><td>Method</td><td>Value</td><td>Range</td><td></td></tr><tr><td rowspan="2">Acetaminophen</td><td rowspan="2">COBAS INTEGRA</td><td>15.1</td><td>10.6 - 19.6 70.0 - 130.0</td><td>μg/mL μmol/L</td></tr><tr><td>100.0 11.2</td><td>7.9 - 14.5</td><td>μg/mL</td></tr><tr><td rowspan="2">Amikacin</td><td rowspan="2">Roche/Hitachi Systems</td><td>74.1</td><td>51.9 - 96.3</td><td>μmol/L</td></tr><tr><td>5.33</td><td>4.25 - 6.41</td><td>μg/mL</td></tr><tr><td rowspan="6">Carbamazepine</td><td rowspan="2">COBAS INTEGRA ONLINE</td><td>9.11</td><td>7.28 - 10.94</td><td>μmol/L</td></tr><tr><td>5.14</td><td>3.91 - 6.37</td><td>μg/mL</td></tr><tr><td rowspan="2"></td><td>8.79</td><td>6.69 - 10.89</td><td>μmol/L</td></tr><tr><td>3.30</td><td>2.64 - 3.96</td><td>μg/mL</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>14.0</td><td>11.3 -16.7</td><td>μmol/L</td></tr><tr><td>3.30</td><td>2.52 - 4.08</td><td>μg/mL</td></tr><tr><td rowspan="2"></td><td>CEDIA Roche/Hitachi</td><td>14.0</td><td>10.7 - 17.3</td><td>μmol/L</td></tr><tr><td></td><td>3.28</td><td>2.62 - 3.94</td><td>μg/mL</td></tr><tr><td rowspan="6">Digoxin</td><td rowspan="2">ONLINE COBAS INTEGRA</td><td>13.9</td><td>11.2 - 16.6</td><td>μmol/L</td></tr><tr><td>0.750</td><td>0.450 - 1.050</td><td></td></tr><tr><td></td><td>0.960</td><td>0.576 - 1.344</td><td>μg/mL μmol/L</td></tr><tr><td>Tina-quant</td><td>0.740</td><td>0.563 - 0.917</td><td></td></tr><tr><td>Roche/hitachi</td><td>0.947</td><td>0.719 - 1.175</td><td>μg/mL μmol/L</td></tr><tr><td></td><td>1.29</td><td>0.90 - 1.68</td><td>μg/mL</td></tr><tr><td rowspan="4"></td><td>CEDIA Roche/Hitachi</td><td>1.65</td><td>1.14-2.16</td><td>μmol/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>2.12</td><td>1.70 - 2.54</td><td>μg/mL</td></tr><tr><td>4.43</td><td>3.53 - 5.33</td><td>μmol/L</td></tr><tr><td rowspan="2">CEDIA Roche/Hitachi</td><td>1.97</td><td>1.49 - 2.45</td><td>μg/mL</td></tr><tr><td>4.12</td><td>3.13 - 5.11</td><td>μmol/L</td></tr><tr><td rowspan="2">Lidocaine</td><td rowspan="2">ONLINE</td><td>2.07 4.33</td><td>1.65 - 2.49 3.46 - 5.20</td><td>μg/mL umol/L</td></tr><tr><td>1.46</td><td>1.16 - 1.76</td><td></td></tr><tr><td></td><td>COBAS INTEGRA</td><td>6.23</td><td>4.97-7.49</td><td>μg/mL μmol/L</td></tr><tr><td rowspan="2">N-acetylprocainamide</td><td>COBAS INTEGRA</td><td>3.96 14.3</td><td>3.18 - 4.74 11.3 -17.3</td><td>μg/mL μmol/L</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>3.87 14.0</td><td>2.94 - 4.80 10.7-17.3</td><td>μg/mL μmol/L</td></tr><tr><td rowspan="2">Phenobarbital</td><td>COBAS INTEGRA</td><td>9.88</td><td>7.90 - 11.86</td><td>μg/mL</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>42.6 9.42</td><td>34.2 -51.0 7.53 - 11.31</td><td>μmol/L μg/mL</td></tr><tr><td rowspan="4">Phenytoin</td><td>COBAS INTEGRA</td><td>40.6 6.37</td><td>32.5 - 48.7 5.11 - 7.63</td><td>μmol/L μg/mL</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>25.2 6.67</td><td>20.1 -30.3 5.08 - 8.26</td><td>μmol/L μg/mL</td></tr><tr><td rowspan="2">CEDIA Roche Hitachi ONLINE</td><td>26.4</td><td>20.1-32.7</td><td>μmol/L</td></tr><tr><td>6.68 26.5</td><td>5.33 - 8.03 21.1-31.9</td><td>μg/mL μmol/L</td></tr><tr><td>Primidone</td><td>COBAS INTEGRA</td><td>2.67 12.2</td><td>2.13 - 3.21 9.8 - 14.6</td><td>μg/mL μmol/L</td></tr><tr><td></td><td>COBAS INTEGRA</td><td>1.76</td><td>1.40 - 2.12</td><td>μg/mL</td></tr><tr><td rowspan="2">Procainamide</td><td></td><td>7.44</td><td>5.94 - 8.94</td><td>μmol/L</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>1.66 7.02</td><td>1.27 - 2.05 5.34 - 8.70</td><td>μg/mL uumol/L</td></tr></table>

TDM Control Set Lot 674373 Level 1   

<table><tr><td rowspan=1 colspan=1>Component</td><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Value</td><td rowspan=1 colspan=1>Range</td><td rowspan=1 colspan=1>Unit</td></tr><tr><td rowspan=2 colspan=1>Quinidine</td><td rowspan=1 colspan=1>COBAS INTEGRA</td><td rowspan=1 colspan=1>1.063.26</td><td rowspan=1 colspan=1>0.85 - 1.272.60 - 3.92</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>ONLINE</td><td rowspan=1 colspan=1>0.9803.02</td><td rowspan=1 colspan=1>0.746 - 1.2142.30 - 3.74</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>Salicylate</td><td rowspan=1 colspan=1>COBAS INTEGRA</td><td rowspan=1 colspan=1>43.10.312</td><td rowspan=1 colspan=1>34.4 - 51.80.249 - 0.375</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=3 colspan=1>Theophylline</td><td rowspan=1 colspan=1>COBAS INTEGRA</td><td rowspan=1 colspan=1>5.3629.7</td><td rowspan=1 colspan=1>4.28 - 6.4423.7 - 35.7</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>CEDIA Roche/Hitachi</td><td rowspan=1 colspan=1>4.9227.3</td><td rowspan=1 colspan=1>3.75 - 6.0920.7 - 33.9</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>ONLINE</td><td rowspan=1 colspan=1>5.3829.9</td><td rowspan=1 colspan=1>4.30 - 6.4623.9 - 35.9</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=2 colspan=1>Tobramycin</td><td rowspan=1 colspan=1>COBAS INTEGRA</td><td rowspan=1 colspan=1>1.553.32</td><td rowspan=1 colspan=1>1.25 - 1.852.66 - 3.98</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>CEDIA Roche/Hitachi</td><td rowspan=1 colspan=1>2.214.73</td><td rowspan=1 colspan=1>1.61 - 2.813.44 - 6.02</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=2 colspan=1>Valproic acid</td><td rowspan=1 colspan=1>COBAS INTEGRA</td><td rowspan=1 colspan=1>36.2251</td><td rowspan=1 colspan=1>29.0 - 43.4200 - 302</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>CEDIA Roche/Hitachi</td><td rowspan=1 colspan=1>40.8283</td><td rowspan=1 colspan=1>30.9 - 50.7214 - 352</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr><tr><td rowspan=1 colspan=1>Vancomycin</td><td rowspan=1 colspan=1>COBAS INTEGRA</td><td rowspan=1 colspan=1>6.874.74</td><td rowspan=1 colspan=1>5.49 - 8.253.78 - 5.70</td><td rowspan=1 colspan=1>μg/mLμmol/L</td></tr></table>

<table><tr><td colspan="5" rowspan="1">TDM Control Set        Lot 674373                  Level lI</td></tr><tr><td colspan="1" rowspan="1">Component</td><td colspan="1" rowspan="1">Method</td><td colspan="1" rowspan="1">Value</td><td colspan="1" rowspan="1">Range</td><td colspan="1" rowspan="1">Unit</td></tr><tr><td colspan="1" rowspan="2">Acetaminophen</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">34.7230</td><td colspan="1" rowspan="1">27.8 - 41.6185 - 275</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">Roche/Hitachi Systems</td><td colspan="1" rowspan="1">30.9205</td><td colspan="1" rowspan="1">23.4 - 38.4157 - 253</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="2">Amikacin</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">14.224.3</td><td colspan="1" rowspan="1">11.5 - 16.919.5 - 29.1</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">ONLINE</td><td colspan="1" rowspan="1">14.524.8</td><td colspan="1" rowspan="1">11.5 - 17.519.7 - 29.9</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="3">Carbamazepine</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">9.5140.2</td><td colspan="1" rowspan="1">7.62 - 11.4032.1 - 48.3</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">CEDIA Roche/Hitachi</td><td colspan="1" rowspan="1">9.3039.3</td><td colspan="1" rowspan="1">7.08 - 11.5230.0 - 48.6</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">ONLINE</td><td colspan="1" rowspan="1">10.142.7</td><td colspan="1" rowspan="1">8.0 - 12.234.3 - 51.1</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="3">Digoxin</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">1.722.20</td><td colspan="1" rowspan="1">1.39-2.051.75 - 2.65</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">Tina-quantRoche/Hitachi</td><td colspan="1" rowspan="1">1.802.30</td><td colspan="1" rowspan="1">1.38 - 2.221.76 - 2.84</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">CEDIA Roche/Hitachi</td><td colspan="1" rowspan="1">2.322.97</td><td colspan="1" rowspan="1">1.75 - 2.892.25 - 3.69</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">Gentamicin</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">5.28</td><td colspan="1" rowspan="1">4.23 - 6.33</td><td colspan="1" rowspan="1">μg/mL</td></tr><tr><td>TDM Control Set</td><td>Lot 674373</td><td>Level II</td><td></td><td></td></tr><tr><td>Component</td><td>Method</td><td>Value</td><td>Range</td><td>Unit</td></tr><tr><td rowspan="4"></td><td></td><td>11.0</td><td>8.9 - 13.1</td><td>μmol/L</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>5.40</td><td>4.11 - 6.69 8.6 - 14.0</td><td>μg/mL</td></tr><tr><td rowspan="2">ONLINE</td><td>11.3 5.43</td><td>4.35 - 6.51</td><td>μmmol/L μg/mL</td></tr><tr><td>11.3</td><td>8.9 - 13.7</td><td>umol/L</td></tr><tr><td rowspan="4">Lidocaine N-acetylprocainamide</td><td rowspan="2">COBAS INTEGRA</td><td>4.26</td><td>3.42 - 5.10</td><td>μg/mL</td></tr><tr><td>18.2</td><td>14.6 - 21.8</td><td>μmol/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>7.23</td><td>5.79 - 8.67</td><td>μg/mL</td></tr><tr><td>26.1</td><td>21.0 -31.2</td><td>umol/L</td></tr><tr><td rowspan="4">Phenobarbital</td><td rowspan="2">CEDIA Roche/Hitachi</td><td>7.19</td><td>5.45 - 8.93</td><td>μg/mL</td></tr><tr><td>26.0</td><td>19.7 -32.3</td><td>mol/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>23.1</td><td>18.6 - 27.6</td><td>μg/mL</td></tr><tr><td>99.6</td><td>79.8 - 119.4</td><td>umol/L</td></tr><tr><td rowspan="5">Phenytoin</td><td rowspan="2">CEDIA Roche/Hitachi</td><td>23.3</td><td>18.5 - 28.1</td><td>μg/mL</td></tr><tr><td>100</td><td>79-121</td><td>umo/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>12.3</td><td>9.9 - 14.7</td><td>μg/mL</td></tr><tr><td>48.7</td><td>39.1 - 58.3</td><td>μmol/L</td></tr><tr><td rowspan="2">CEDIA Roche/Hitachi</td><td>13.3</td><td>10.0 - 16.6</td><td>μg/mL</td></tr><tr><td>52.7 13.0</td><td>40.1 -65.3 10.3 - 15.7</td><td>μmol/L</td></tr><tr><td>Primidone</td><td>ONLINE</td><td>51.5 7.74</td><td>41.3-61.7 6.18 - 9.30</td><td>μg/mL μmol/L</td></tr><tr><td></td><td>COBAS INTEGRA</td><td>35.4</td><td>28.2 - 42.6</td><td>μg/mL umol/L</td></tr><tr><td rowspan="6">Procainamide</td><td rowspan="2">COBAS INTEGRA</td><td>7.30</td><td>5.83 - 8.77</td><td>μg/mL</td></tr><tr><td>30.9</td><td>24.6 - 37.2</td><td>umol/L</td></tr><tr><td rowspan="2">CEDIA Roche/Hitachi</td><td>7.04</td><td>5.36 - 8.72</td><td>μg/mL</td></tr><tr><td>29.8</td><td>22.6 -37.0</td><td>μmol/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td></td><td>2.38 - 3.58</td><td></td></tr><tr><td>2.98</td><td></td><td>μg/mL</td></tr><tr><td rowspan="2">Salicylate</td><td rowspan="2">ONLINE</td><td>9.18</td><td>7.35- 11.01</td><td>μmmol/L</td></tr><tr><td>2.90 8.93</td><td>2.33 - 3.47 7.13-10.73</td><td>μg/mL μmol/L</td></tr><tr><td></td><td>COBAS INTEGRA</td><td>162</td><td>129 - 195 0.93 - 1.41</td><td>μg/mL</td></tr><tr><td rowspan="4">Theophylline</td><td rowspan="2">COBAS INTEGRA</td><td>1.17</td><td>11.7- 17.7</td><td>umol/L</td></tr><tr><td>14.7</td><td></td><td>μg/mL</td></tr><tr><td rowspan="2">CEDIA Roche/Hitachi</td><td>81.6</td><td>65.4 - 97.8</td><td>ummol/lL</td></tr><tr><td>14.1</td><td>10.8 - 17.4</td><td>μg/mL</td></tr><tr><td rowspan="4">Tobramycin</td><td rowspan="2">ONLINE</td><td>78.3</td><td>59.4 - 97.2 11.6 - 17.6</td><td>μmol/L</td></tr><tr><td>14.6</td><td>64.8 -97.2</td><td>μg/mL μmol/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>81.0</td><td>2.90 - 4.34</td><td>μg/mL</td></tr><tr><td>3.62 7.75</td><td>6.19 - 9.31</td><td>μmol/L</td></tr><tr><td rowspan="4"></td><td rowspan="2">CEDIA Roche/Hitachi</td><td>4.86</td><td>3.54 - 6.18</td><td>μg/mL</td></tr><tr><td>10.4</td><td>7.7 - 13.1</td><td>μmol/L</td></tr><tr><td rowspan="2">COBAS INTEGRA</td><td>76.9</td><td>61.6 - 92.2</td><td>μg/mL</td></tr><tr><td>533</td><td>425 -641</td><td>μmol/L</td></tr><tr><td rowspan="3">Valproic acid Vancomycin</td><td rowspan="2">CEDIA Roche/Hitachi</td><td>85.2</td><td>64.8- 105.6</td><td>μg/mL</td></tr><tr><td>590</td><td>449 -731</td><td>μmol/L</td></tr><tr><td>COBAS INTEGRA</td><td>22.3</td><td>17.8 - 26.8</td><td>ug/mL</td></tr><tr><td></td><td></td><td>15.4</td><td>12.4 - 18.4</td><td>μmol/L</td></tr></table>

<table><tr><td colspan="5"></td></tr><tr><td>TDM Control Set</td><td>Lot 674373</td><td>Level III</td><td></td><td>Unit</td></tr><tr><td>Component</td><td>Method</td><td>Value 109</td><td>Range 88 - 130</td><td>μg/mL</td></tr><tr><td rowspan="2">Acetaminophen</td><td rowspan="2">COBAS INTEGRA</td><td>722</td><td>578 - 866</td><td>μmol/L</td></tr><tr><td>105</td><td>81- 129</td><td>μg/mL</td></tr><tr><td rowspan="4">Amikacin</td><td rowspan="2">Roche/Hitachi Systems COBAS INTEGRA</td><td>695</td><td>527 - 863</td><td>μmmol/L</td></tr><tr><td>26.4</td><td>21.0 - 31.8</td><td>μg/mL</td></tr><tr><td rowspan="2">ONLINE</td><td>45.1</td><td>36.1 -54.1</td><td>umol/L</td></tr><tr><td>29.8</td><td>23.8 - 35.8</td><td>μg/mL</td></tr><tr><td rowspan="5">Carbamazepine</td><td>COBAS INTEGRA</td><td>51.0 15.6</td><td>40.8 -61.2 12.6 - 18.6</td><td>umol/L μg/mL</td></tr><tr><td rowspan="2">CEDIA Roche/Hitachi</td><td>66.0 14.8</td><td>52.8 - 79.2</td><td>μmol/L</td></tr><tr><td></td><td>11.2 - 18.4</td><td>μg/mL</td></tr><tr><td rowspan="2"></td><td>62.6</td><td>47.6 -77.6</td><td>μmol/L</td></tr><tr><td>15.6</td><td>12.6 - 18.6</td><td>μg/mL</td></tr><tr><td rowspan="5">Digoxin</td><td rowspan="2">ONLINE COBAS INTEGRA</td><td>66.0</td><td>52.8 - 79.2</td><td>umol/L</td></tr><tr><td>3.48</td><td>2.10 - 4.86</td><td>μg/mL</td></tr><tr><td rowspan="2">Tina-quant</td><td>4.45</td><td>2.68 - 6.22</td><td>μmol/L</td></tr><tr><td>3.54</td><td>2.70 - 4.38</td><td>μg/mL</td></tr><tr><td>Roche/Hitachi</td><td>4.53 3.95</td><td>3.45 - 5.61</td><td>μmol/L</td></tr><tr><td rowspan="4">Gentamicin</td><td rowspan="2">CEDIA Roche/Hitachi</td><td></td><td>2.99 - 4.91 3.86 - 6.26</td><td>μg/mL umol/L</td></tr><tr><td>5.06</td><td>6.45 - 9.69</td><td></td></tr><tr><td rowspan="2">COBAS INTEGRA CEDIA Roche/Hitachi</td><td>8.07 16.9</td><td>13.6 - 20.2</td><td>μg/mL mmol/L</td></tr><tr><td>8.31</td><td>6.06 - 10.56</td><td>μg/mL</td></tr><tr><td rowspan="2"></td><td rowspan="2">ONLINE</td><td>17.4 8.31 17.4</td><td>12.6-22.2</td><td>mol/L</td></tr><tr><td></td><td>6.66 - 9.96 13.8 - 21.0</td><td>μg/mL umol/L</td></tr><tr><td>Lidocaine</td><td>COBAS INTEGRA</td><td>6.46 27.6</td><td>5.17-7.75</td><td>μg/mL</td></tr><tr><td></td><td>COBAS INTEGRA</td><td>12.1</td><td>22.2 -33.0 9.7 - 14.5</td><td>μmol/L μg/mL</td></tr><tr><td rowspan="2">N-acetylprocainamide</td><td></td><td>43.7 12.7</td><td>35.0 - 52.4</td><td>mol/L</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>45.8</td><td>9.7 - 15.7 34.7 - 56.9</td><td>μg/mL umol/L</td></tr><tr><td rowspan="6">Phenobarbital Phenytoin</td><td>COBAS INTEGRA</td><td>42.8 184</td><td>34.1-51.5 148 - 220</td><td>μg/mL μmol/L</td></tr><tr><td>CEDIA Roche/Hitachi</td><td>45.3 195</td><td>36.3 - 54.3 156 - 234</td><td>μg/mL μmol/L</td></tr><tr><td>COBAS INTEGRA</td><td>22.1 87.5</td><td>17.6 - 26.6 70.1 - 104.9</td><td>μg/mL μmmol/L</td></tr><tr><td rowspan="2">CEDIA Roche/Hitachi</td><td>24.0</td><td>18.3 - 29.7</td><td>μg/mL</td></tr><tr><td>95.0</td><td>72.2-117.8</td><td>mol/L</td></tr><tr><td>ONLINE</td><td>22.8 90.3</td><td>18.3 - 27.3 72.3 - 108.3</td><td>μg/mL</td></tr><tr><td></td><td></td><td>16.1</td><td>12.8 - 19.4</td><td>μmol/L</td></tr><tr><td>Primidone</td><td>COBAS INTEGRA</td><td>73.7</td><td>59.0 - 88.4</td><td>μg/mL umol/L</td></tr><tr><td colspan="5" rowspan="1">TDM Control Set        Lot 674373                  Level III</td></tr><tr><td colspan="1" rowspan="1">Component</td><td colspan="1" rowspan="1">Method</td><td colspan="1" rowspan="1">Value</td><td colspan="1" rowspan="1">Range</td><td colspan="1" rowspan="1">Unit</td></tr><tr><td colspan="1" rowspan="2">Procainamide</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">11.548.6</td><td colspan="1" rowspan="1">9.1 - 13.939.0 - 58.2</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">CEDIA Roche/Hitachi</td><td colspan="1" rowspan="1">10.644.8</td><td colspan="1" rowspan="1">8.2 - 13.034.0 - 55.6</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="2">Quinidine</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">4.7814.7</td><td colspan="1" rowspan="1">3.82 - 5.7411.7 - 17.7</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">ONLINE</td><td colspan="1" rowspan="1">4.5914.1</td><td colspan="1" rowspan="1">3.66 - 5.5211.4 - 16.8</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">Salicylate</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">4423.20</td><td colspan="1" rowspan="1">355 - 5292.57 - 3.83</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="3">Theophylline</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">29.5164</td><td colspan="1" rowspan="1">23.5 - 35.5131 - 197</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">CEDIA Roche/Hitachi</td><td colspan="1" rowspan="1">28.5158</td><td colspan="1" rowspan="1">21.6 - 35.4119 - 197</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">ONLINE</td><td colspan="1" rowspan="1">29.6164</td><td colspan="1" rowspan="1">23.6 - 35.6131 - 197</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="2">Tobramycin</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">7.6816.4</td><td colspan="1" rowspan="1">6.15 - 9.2113.1 - 19.7</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">CEDIA Roche/Hitachi</td><td colspan="1" rowspan="1">9.8221.0</td><td colspan="1" rowspan="1">7.18 - 12.4615.3 - 26.7</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="2">Valproic acid</td><td colspan="1" rowspan="1">COBAS INTEGRACOBAS INTEGRA</td><td colspan="1" rowspan="1">122845</td><td colspan="1" rowspan="1">98 - 146677 - 1.013</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">CEDIA Roche/Hitachi</td><td colspan="1" rowspan="1">132915</td><td colspan="1" rowspan="1">96 - 168669 - 1.161</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr><tr><td colspan="1" rowspan="1">Vancomycin</td><td colspan="1" rowspan="1">COBAS INTEGRA</td><td colspan="1" rowspan="1">35.224.3</td><td colspan="1" rowspan="1">28.3 - 42.119.5 - 29.1</td><td colspan="1" rowspan="1">μg/mLμmol/L</td></tr></table>

The sponsor performed the following studies to verify the stability claims for the TDM Control Set.

<table><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Unopened</td><td rowspan=1 colspan=1>Opened</td></tr><tr><td rowspan=1 colspan=1>TDMControl Set</td><td rowspan=1 colspan=1>Store at 2 - 8°Cuntilexpiration date</td><td rowspan=1 colspan=1>12 months at 28°C.</td></tr></table>

Unopened: The TDM Control Set products were stored at $4 5 \mathrm { { ^ \circ C } }$ for 10 days, $3 7 \mathrm { { ^ \circ C } }$ every other day for 20 days, $3 2 \mathrm { { ^ \circ C } }$ every third day for 30 days for a total of ten bottles per level. Each vial was assayed in triplicate using the Integra 400 and compared to the reference that was initially stored at- ${ 7 0 \mathrm { \% } }$ . The product met the sponsor’s acceptance criterion $9 5 \mathrm { - } 1 0 5 \%$ of the reference). The sponsor is continuing real-time stability studies using the COBAS Integra TDM Assays on the Integra 400 or 700 analyzers.

Opened: The TDM Control Set products were sampled frequently over 120 days. Vials were tested every 30 days and compared to newly opened vials of TDM Contro

Set products. The product met the sponsor’s acceptance criterion (recovery at $\pm 5 \%$ of the newly opened vials.) The sponsor is continuing opened vial real-time stability studies.

d. Detection limit: Not applicable   
e. Analytical specificity: Not applicable   
f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable   
b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable   
b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

N. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.